Skip to content
10-Q

Quarterly Report

Editas Medicine, Inc. EDIT

0001650664-25-000156

← back to feed
Filed
Nov 10, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 31, 2025 97.62M sh
Shares Diluted Q3 2025 · Sep 30, 2025 90.09M sh
Shares Diluted Q3 2025 · Sep 30, 2025 85.88M sh
Shares Diluted Q3 2025 · Sep 30, 2024 82.49M sh
Shares Diluted Q3 2025 · Sep 30, 2024 82.25M sh
Capex Q3 2025 · Sep 30, 2025 $547K
Capex Q3 2025 · Sep 30, 2024 $8.29M
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$128.85M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$159.52M
Long Term Debt Q3 2025 · Sep 30, 2025 $54.07M
Long Term Debt Q3 2025 · Dec 31, 2024 $52.43M
Short Term Debt Q3 2025 · Sep 30, 2025 $5M
Short Term Debt Q3 2025 · Dec 31, 2024 $5M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $165.65M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $131.54M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $95.83M
Stockholders Equity Q3 2025 · Sep 30, 2025 $13.45M
Stockholders Equity Q3 2025 · Jun 30, 2025 $19.19M
Stockholders Equity Q3 2025 · Mar 31, 2025 $62.42M
Stockholders Equity Q3 2025 · Dec 31, 2024 $134.27M
Stockholders Equity Q3 2025 · Sep 30, 2024 $175.63M
Stockholders Equity Q3 2025 · Jun 30, 2024 $232.01M
Stockholders Equity Q3 2025 · Mar 31, 2024 $294.4M
Stockholders Equity Q3 2025 · Dec 31, 2023 $349.1M
Current Liabilities Q3 2025 · Sep 30, 2025 $61.77M
Current Liabilities Q3 2025 · Dec 31, 2024 $77.23M
Total Liabilities Q3 2025 · Sep 30, 2025 $188.3M
Total Liabilities Q3 2025 · Dec 31, 2024 $207.32M
Current Assets Q3 2025 · Sep 30, 2025 $176.89M
Current Assets Q3 2025 · Dec 31, 2024 $289.32M
Total Assets Q3 2025 · Sep 30, 2025 $201.75M
Total Assets Q3 2025 · Dec 31, 2024 $341.59M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.28
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.80
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.75
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.33
Eps Basic Q3 2025 · Sep 30, 2025 −$0.28
Eps Basic Q3 2025 · Sep 30, 2025 −$1.80
Eps Basic Q3 2025 · Sep 30, 2024 −$0.75
Eps Basic Q3 2025 · Sep 30, 2024 −$2.33
Sga Expense Q3 2025 · Sep 30, 2025 $12.32M
Sga Expense Q3 2025 · Sep 30, 2025 $38.55M
Sga Expense Q3 2025 · Sep 30, 2024 $18.09M
Sga Expense Q3 2025 · Sep 30, 2024 $55.63M
Rd Expense Q3 2025 · Sep 30, 2025 $19.78M
Rd Expense Q3 2025 · Sep 30, 2025 $62.55M
Rd Expense Q3 2025 · Sep 30, 2024 $47.64M
Rd Expense Q3 2025 · Sep 30, 2024 $150.64M
Net Income Q3 2025 · Sep 30, 2025 −$25.12M
Net Income Q3 2025 · Sep 30, 2025 −$154.44M
Net Income Q3 2025 · Jun 30, 2025 −$53.24M
Net Income Q3 2025 · Mar 31, 2025 −$76.09M
Net Income Q3 2025 · Sep 30, 2024 −$62.14M
Net Income Q3 2025 · Sep 30, 2024 −$191.7M
Net Income Q3 2025 · Jun 30, 2024 −$67.61M
Net Income Q3 2025 · Mar 31, 2024 −$61.95M
Operating Income Q3 2025 · Sep 30, 2025 −$24.55M
Operating Income Q3 2025 · Sep 30, 2025 −$152.26M
Operating Income Q3 2025 · Sep 30, 2024 −$65.67M
Operating Income Q3 2025 · Sep 30, 2024 −$204.56M
Revenue Q3 2025 · Sep 30, 2025 $7.54M
Revenue Q3 2025 · Sep 30, 2025 $15.78M
Revenue Q3 2025 · Sep 30, 2024 $61K
Revenue Q3 2025 · Sep 30, 2024 $1.71M